Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes

被引:154
作者
Matsumura, T [1 ]
Ito, A [1 ]
Takii, T [1 ]
Hayashi, H [1 ]
Onozaki, K [1 ]
机构
[1] Nagoya City Univ, Fac Pharmaceut Sci, Dept Hyg Chem, Mizuho Ku, Nagoya, Aichi 4678603, Japan
关键词
D O I
10.1089/10799900050163299
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptor (TLR) 2 and TLR4 are members of the interleukin-1 receptor (IL-1R) family and transduce similar signals as IL-1R in response to bacteria and bacterial components. In this study, we investigated the regulation of their gene expression in murine tissues, especially in the liver and hepatocytes. When mice were administered lipopolysaccharide (LPS), TLR2 mRNA was upregulated in the brain, heart, lung, liver, and kidney. In contrast, it was downregulated in the spleen. TLR4 mRNA was decreased in the brain. In the heart and lung, it increased, and it was not affected in the liver, kidney, and spleen. TLR mRNA was further analyzed in the liver and hepatocytes. Like LPS treatment, administration of IL-1, IL-6, or tumor necrosis factor (TNF) upregulated TLR2 mRNA. However, none of them affected the TLR4 mRNA level. In primary cultured hepatocytes, TLR2 mRNA was upregulated by LPS, IL-1, or TNF but not by IL-6 or dexamethasone. None of them affected TLR4 mRNA expression. Similar responses were observed in the murine hepatoma cell line Hepa 1-6. These results suggest that in infection with gram-negative bacteria, LPS and proinflammatory cytokines differentially regulate gene expression of TLR2 and TLR4 in murine hepatocytes, which may lead to pathologic and host defense reactions in the liver.
引用
收藏
页码:915 / 921
页数:7
相关论文
共 54 条
  • [41] Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14
    Schumann, RR
    Pfeil, D
    Lamping, N
    Kirschning, C
    Scherzinger, G
    Schlag, P
    Karawajew, L
    Herrmann, F
    [J]. BLOOD, 1996, 87 (07) : 2805 - 2814
  • [42] Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
    Schwandner, R
    Dziarski, R
    Wesche, H
    Rothe, M
    Kirschning, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17406 - 17409
  • [43] MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
    Shimazu, R
    Akashi, S
    Ogata, H
    Nagai, Y
    Fukudome, K
    Miyake, K
    Kimoto, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) : 1777 - 1782
  • [44] TLR6: A novel member of an expanding Toll-like receptor family
    Takeuchi, O
    Kawai, T
    Sanjo, H
    Copeland, NG
    Gilbert, DJ
    Jenkins, NA
    Takeda, K
    Akira, S
    [J]. GENE, 1999, 231 (1-2) : 59 - 65
  • [45] Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway
    Takeuchi, O
    Kaufmann, A
    Grote, K
    Kawai, T
    Hoshino, K
    Morr, M
    Muhlradt, PF
    Akira, S
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (02) : 554 - 557
  • [46] Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
    Takeuchi, O
    Hoshino, K
    Kawai, T
    Sanjo, H
    Takada, H
    Ogawa, T
    Takeda, K
    Akira, S
    [J]. IMMUNITY, 1999, 11 (04) : 443 - 451
  • [47] Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades
    Takeuchi, O
    Takeda, K
    Hoshino, K
    Adachi, O
    Ogawa, T
    Akira, S
    [J]. INTERNATIONAL IMMUNOLOGY, 2000, 12 (01) : 113 - 117
  • [48] Tapping RI, 2000, CHEM IMMUNOL, V74, P108
  • [49] Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
    Underhill, DM
    Ozinsky, A
    Smith, KD
    Aderem, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) : 14459 - 14463
  • [50] Vogel SN, 1999, J IMMUNOL, V162, P5666